Urinary C-peptide creatinine ratio detects absolute insulin deficiency in Type 2 diabetes. - Wikidata - awgldk - TriplyDB

Urinary C-peptide creatinine ratio detects absolute insulin deficiency in Type 2 diabetes.

Urinary C-peptide creatinine ratio detects absolute insulin deficiency in Type 2 diabetes.

http://www.wikidata.org/entity/Q34131203

about

A Practical Review of C-Peptide Testing in Diabetes Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia.Detection of C-Peptide in Urine as a Measure of Ongoing Beta Cell Function.

P2860

Q33732640-812E183C-5DFB-44BF-A44E-565818044971 Q47567739-D7344086-0442-4E0A-9573-F30078EE37BB Q52874770-F8C4A0E4-F232-4A94-9734-3BC5DC1A4FF6

P2860

Urinary C-peptide creatinine ratio detects absolute insulin deficiency in Type 2 diabetes.

http://www.wikidata.org/entity/Q34131203

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Urinary C-peptide creatinine r ...... deficiency in Type 2 diabetes.

@ast

Urinary C-peptide creatinine r ...... deficiency in Type 2 diabetes.

@en

Urinary C-peptide creatinine r ...... deficiency in Type 2 diabetes.

@nl

type

label

Urinary C-peptide creatinine r ...... deficiency in Type 2 diabetes.

@ast

Urinary C-peptide creatinine r ...... deficiency in Type 2 diabetes.

@en

Urinary C-peptide creatinine r ...... deficiency in Type 2 diabetes.

@nl

prefLabel

Urinary C-peptide creatinine r ...... deficiency in Type 2 diabetes.

@ast

Urinary C-peptide creatinine r ...... deficiency in Type 2 diabetes.

@en

Urinary C-peptide creatinine r ...... deficiency in Type 2 diabetes.

@nl

P1433

Q34131203-70C15CE2-A08C-4B73-8F0F-9B8B607B1ED8

P1476

Q34131203-65CF3936-5EE9-46C1-8C7F-09CE0B124825

P2093

Q34131203-14990353-3BE1-41C0-88E3-0C907E808C66

Q34131203-24B732A0-8BE6-4F62-ADDA-3DEA1861416C

Q34131203-59CAC6FB-5526-41DD-AAC5-FFDDC3838BCB

Q34131203-959BCDCE-B0AC-4FF9-BC78-643E345F3FAE

Q34131203-F4CFB28E-56EE-4D4A-91D3-5934E402BF01

P2860

Q34131203-26E21ADC-2A49-461D-A4EC-52172B724265

Q34131203-3DCC8673-56C8-472F-9341-CD0F597469A5

Q34131203-4DB1C4A8-0320-4D68-852F-17B56E4AB11C

Q34131203-71EB5979-BCBB-443F-ADDE-9E187489ECBE

Q34131203-7F94DF6B-1B27-4934-A01D-1D5A475AA1A4

Q34131203-8751A9C7-55EB-43C1-8077-AB0423D449EC

Q34131203-8D2DB853-065F-413E-A738-DC1738188C5A

Q34131203-9821DD83-92FD-402E-993F-D7E14C867D63

Q34131203-9FF542B1-29EB-46AA-83D2-0A1FBB699218

Q34131203-B4BCE898-154C-4C25-90F3-B80007A96705

P304

Q34131203-A3A0A622-84EC-447A-9E51-C45A85B33A0D

P31

Q34131203-D97E3701-175D-4AC5-AF42-0DE283CAEFB8

P356

Q34131203-8AF3BB30-BAB1-4F02-89EF-5FB3011EA8D1

P433

Q34131203-E1CDBE5B-D8EE-4AFC-8668-8F389160713A

P478

Q34131203-F58230DD-279C-4E28-BFAC-1E26C5676BBD

P50

Q34131203-0707F671-947C-493C-8160-E6FAE28AB3FA

Q34131203-2C6D5598-4071-497B-9DC3-5DA41D6F8C34

Q34131203-6A497EDC-B199-429C-9524-C39D436C88FE

Q34131203-D85F3B0E-DE0E-470D-8111-BE92F7550F3F

P577

Q34131203-E8568940-C81D-4337-AF38-B588DA6775B8

P5875

Q34131203-4841DDFA-A75A-4D28-9E7B-9C8B258F6BAE

P698

Q34131203-967AEB9A-67B7-4EF3-8F43-5F5E22DB255D

P921

Q34131203-63B9E1A8-9CEB-4D6A-B6DB-2A2280AA3BC2

Q34131203-9E6902E9-6E8E-4D42-AD61-334CE05A0DA0

P932

Q34131203-E83D5E05-BFC1-4A85-A2D3-D4D0DAA9DE76

P356

P1433

Diabetic Medicine

P1476

Urinary C-peptide creatinine ratio detects absolute insulin deficiency in Type 2 diabetes

@en

P2093

B A Knight

http://www.w3.org/2001/XMLSchema#string

B Shields

http://www.w3.org/2001/XMLSchema#string

E Goodchild

http://www.w3.org/2001/XMLSchema#string

M Shepherd

http://www.w3.org/2001/XMLSchema#string

R E J Besser

http://www.w3.org/2001/XMLSchema#string

P2860

Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease

EDTA improves stability of whole blood C-peptide and insulin to over 24 hours at room temperature.

Urine C-peptide creatinine ratio is a noninvasive alternative to the mixed-meal tolerance test in children and adults with type 1 diabetes.

Six-year follow-up of pancreatic beta cell function in adults with latent autoimmune diabetes

Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes

The clinical utility of C-peptide measurement in the care of patients with diabetes

Stability and reproducibility of a single-sample urinary C-peptide/creatinine ratio and its correlation with 24-h urinary C-peptide.

Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial.

The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study.

C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.

P304

1342-1348

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/DME.12222

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

Andrew Tym Hattersley

Timothy J McDonald

P577

2013-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236673664

http://www.w3.org/2001/XMLSchema#string

P698

23659458

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

4154136

http://www.w3.org/2001/XMLSchema#string